Phalen Michael P. 4
4 · BOSTON SCIENTIFIC CORP · Filed Feb 26, 2018
Insider Transaction Report
Form 4
Phalen Michael P.
SVP & President, Endoscopy
Transactions
- Exercise/Conversion
Common Stock
2018-02-23+2,452→ 128,190 total - Exercise/Conversion
Common Stock
2018-02-24+3,440→ 130,540 total - Tax Payment
Common Stock
2018-02-24$27.20/sh−1,530$41,616→ 129,010 total - Exercise/Conversion
Deferred Stock Units
2018-02-24−3,440→ 3,441 totalExercise: $0.00Exp: 2019-02-24→ Common Stock (3,440 underlying) - Tax Payment
Common Stock
2018-02-23$27.20/sh−1,090$29,648→ 127,100 total - Exercise/Conversion
Deferred Stock Units
2018-02-23−2,452→ 4,906 totalExp: 2020-02-23→ Common Stock (2,452 underlying)
Footnotes (4)
- [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F2]Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- [F3]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.
- [F4]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.